Active	Status	Sponsor type	Region	Phase	Filter
11 Active 2 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Krok, Karen L
NCT06174272: Transitional Care Program for Fluid Overload in Cirrhosis	Recruiting	N/A	20	US	Transitional Care Program	Milton S. Hershey Medical Center	Cirrhosis, Liver	06/25	06/26
Longenecker, Amy
PRECISE, NCT06428955: Evaluation of a Monofocal Intraocular Lens	Recruiting	4	44	US, RoW	CT LUCIA 621P	Carl Zeiss Meditec AG	Cataract	12/24	12/24
NCT04414514: Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment	Recruiting	2	24	US	Ruxolitinib 1.5% Cream	Milton S. Hershey Medical Center, Incyte Corporation	Hidradenitis Suppurativa	10/26	01/28
Raman, Jay
ADAPT-PSA, NCT05629494: Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test	Recruiting	4	198	US	Ibuprofen 400 mg, TID, Motrin, PSA test	Albany Medical College	Prostate Cancer, Prostate Inflammation, PSA	03/26	12/26
NCT05512754: Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen	Recruiting	4	200	US	Ibuprofen 400 mg, Advil	University of Chicago	Elevated Serum PSA	08/25	08/25
ENLIGHTED, NCT04620239 / 2020-004494-41: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study	Recruiting	3	100	Europe, US, RoW	padeliporfin VTP, WST11	Steba Biotech S.A., PrimeVigilance, ICON plc	Transitional Cell Cancer of Renal Pelvis and Ureter	12/24	01/29
NCT06774131: A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer	Not yet recruiting	3	50	US	UGN-104, UGN-104 (mitomycin) for pyelocalyceal solution	UroGen Pharma Ltd.	Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma	03/26	03/27
NCT05375903: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)	Recruiting	1	60	Europe, US	UGN-301, UGN-301 (zalifrelimab) intravesical solution, UGN-201, UGN-201 (imiquimod) intravesical solution, Gemcitabine	UroGen Pharma Ltd.	Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent	12/25	12/25
NCT06422312: A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.	Not yet recruiting	N/A	140	US	Cystoscopy with RedPine flexible disposable cystoscope, Cystoscopy with standard of care flexible reusable scope	Guangzhou Red Pine Medical Instrument Co., Ltd., University of Texas Southwestern Medical Center, University of Washington, Penn State University	Bladder Cancer, Bladder Stone, Bladder Outlet Obstruction, Renal Stone, Renal Disease	01/25	07/25
NCT03988309: STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA	Active, not recruiting	N/A	554	Canada, US	Cxbladder	Pacific Edge Limited	Hematuria, Urothelial Carcinoma	12/24	12/24
Lehman, Kathy
NCT03988309: STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA	Active, not recruiting	N/A	554	Canada, US	Cxbladder	Pacific Edge Limited	Hematuria, Urothelial Carcinoma	12/24	12/24